Duane Roth: Ecumenical Innovator for San Diego and Biotech
By Dr. Matthew Watson
a sterling look at the contributions that Duane Roth, co-vice
chairman of the California stem cell agency, made before his untimely
death as the result of a bicycle accident.
a host of comments concerning Roth's involvement in the San Diego
community, ranging from biotech to action sports companies. The
headline on the piece read, “The Connector Who Wired up a Regional
Innovation Economy.”
63, Roth was CEO of Connect, a nonprofit organization that supported
technology and innovation and one that he was credited with reviving.
Bigelow also wrote,
“Once California voters approved a
2004 ballot proposition that authorized the issuance of $3 billion in
grants for stem cell R&D, (Mary) Walshok (associate vice
chancellor for public programs at UC San Diego) said Roth also played
a key role in bringing together UCSD, Scripps, Salk, and
Sanford-Burnham to create the Sanford Consortium for Regenerative
Medicine. In fact, Walshok doubts whether anyone but Duane Roth could
have brought the four major research centers together.”
services Friday attended by about 1,000 persons was Bill Walton, the
former UCLA and NBA great, who grew up in San Diego.
“Walton, the NBA Hall of Famer who
has led San Diego Sports Innovators as a division of Connect since
2010, said Roth became a business mentor to him. In his comments
Friday afternoon, Walton said Roth inspired him to be a better
person, and he counted Roth among the people who had the biggest
influence on his life—a list that included his own father, UCLA
coach John Wooden, sportscaster Chick Hearn, author David Halberstam,
and Jerry Garcia of the Grateful Dead.”
and pragmatic advocate for innovation who could work with persons who
did not always agree with him on all issues. He was a conservative
and active Republican, but his co-vice chair at at the stem cell
agency, Art Torres, former chairman of the state Democratic Party, on
more than one occasion has lauded Roth's ability to work together.
Friday by Don Rosenberg, an executive vice president and general
counsel at Qualcomm.
“'Duane and I were as different as
two people can be,' Rosenberg said during his eulogy at the Church of
the Immaculata. 'Duane was born in Iowa, baptized in the Mennonite
church, a Republican. And me, raised in Brooklyn, Jewish, a Democrat.
We quickly learned we had more in common. We were kindred spirits. We
liked the same things: Bikes, biking, cars, and people.'”
Source:
Stem Cell Therapy
Comments Off on Duane Roth: Ecumenical Innovator for San Diego and Biotech |
August 18th, 2013
A $6 Billion Question: Progress of the California Stem Cell Agency
By Dr. Matthew Watson
Internet and throughout the world.
rare headline that sounds a harshly different note:
one form or another, a request/question posed last month by an
anonymous reader of the California Stem Cell Report. The comment came
on an item about the California stem cell agency's $70 million plan
to establish a network of “Alpha” stem cell clinics in
California.
“It would be nice to have an overall
update on how much as been spent on California's stem cell research
project and what progress has been made.”
agency has given away $1.8 billion. The agency says it has made
tremendous progress and expects to make even more with the about $600
million it has left. The prestigious Institute of Medicine has said the
agency has “achieved many notable results.”
evaluation has been made of the details of the agency's scientific
contributions, specific grant awards or its impact on the field of
regenerative medicine. No one has attempted to genuinely assess
whether the work of the agency is or will be worth the roughly $6
billion(including interest) that California taxpayers will have paid
for the agency's ambitious efforts.
towards what?” Is the progress to be measured against the promises
of the 2004 ballot campaign that resulted in creation of the stem
cell agency or more modest goals that eschew the hype of the
campaign?
created a sort of contract with voters. They were led to
believe nine years ago that the cures for diseases that the campaign said afflict nearly
one-half of all California families were, in fact, right around the corner. Few,
if any California stem cell researchers were publicly warning that a
hard and long, long slog remained before therapies reached patients.
British newspapers, The Guardian and Observer, shed some light on the
early, rosy promises of stem cell science compared to the world as it exists
today.
“(B)iomedical engineer Professor
Michael Sefton declared that within 10 years, scientists would have
grown an entire heart, fit for transplant. 'We're shooting big,' he
said. 'Our vision is that we'll be able to pop out a damaged heart
and replace it as easily as you would replace a carburetor in a car.'“Fifteen years on, however, we've had
some liver cells, eye cells, even a lab-grown
burger, but no whole human organs. We could be forgiven for
asking: where's our heart? It does seem strange that a field stoking
so much excitement could be so far off the mark. Speaking last week
about the vision that he and his colleagues outlined in 1998, Sefton
said they had been 'hopelessly naïve.' As time plodded on and an
understanding of the biological complexity increased, the task seemed
bigger and bigger. Even now, a cacophony of headlines later, we are
not much further ahead.
“Chris Mason is a professor of
regenerative medicine at University College London and believes that
concentrating on organ regeneration is missing a trick. 'These organs
are immensely complex,' he said. 'They've got nerves, blood vessels,
in the case of the liver, a bile system – there are huge degrees of
complexity. These things take a long time to grow in humans, let
alone in the lab without all the natural cues that occur in the
growing embryo.'"
said,
“There's a tension in medical
research between the glory of the big discovery and the
assiduous commitment to real application. 'We're hoping the scope and
possibilities of this project will catch the public's imagination,'
Sefton concluded in 1998. It did, but perhaps the public's
imagination isn't always what science should be vying for.”
stem cell agency has made a significant contribution to stem cell
science, although the size of that contribution – beyond dollars –
remains to be measured. For now, the key for the agency and the
public is to focus on activities that will generate the greatest value over the
next few years and advance the science that has already been financed
by the agency.
report said,
“The challenge of moving its research
programs closer to the clinic and California’s large biotechnology
sector is certainly on CIRM’s agenda, but substantial achievements
in this arena remain to be made.”
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/O78NzUdZE88/a-6-billion-question-progress-of.html
Stem Cell Therapy
Comments Off on A $6 Billion Question: Progress of the California Stem Cell Agency |
August 18th, 2013
Stem Cell Agency’s Duane Roth Eulogized at Memorial Services
By Dr. Matthew Watson
services last week for Duane Roth, co-vice chairman of the California
stem cell agency, who died at the age of 63 following a bicycle
accident.
“A Who’s
Who of San Diego’s technology, business and civic community
gathered Friday to bid farewell to Duane Roth.
The biotech entrepreneur, community leader and director of Connect
died last weekend of injuries sustained in a cycling accident.
“Among
attendees were Gayle and former Gov. Pete
Wilson, who had just celebrated his upcoming 80th birthday
with former colleagues and friends in Sacramento, county
Supervisor Ron Roberts, former
Assemblyman Nathan Fletcher, Chamber
head Jerry Sanders, Preuss School
benefactors Peggy and Peter
Preuss, SDG&E CEO Jessie Knight,
and many biotech and high-tech leaders. These included Irwin
Jacobs, Ted Waitt and Denny
Sanford.”
Source:Stem Cell Therapy
Comments Off on Stem Cell Agency’s Duane Roth Eulogized at Memorial Services |
August 18th, 2013
‘Paradigm Shift’ — Researchers as Patient Advocates?
By Dr. Matthew Watson
scientist to break into “print” in that bastion of American
capitalism, Forbes magazine. Much less one from that perceived
antithesis of free enterprise, Reed College.
Davis has done just that.
Friday in the wake of the announcement Knoepfler will be honored with
a “national advocacy” award by the Genetics Policy Institute.
 |
| Paul Knoepfler -- Advocate for a "new ethos" UC Davis photo |
English literature from Reed in 1989, is being recognized for his
activities as a stem cell blogger since 2009.
an email,
“With many stumbles, face plants,
land mines, and even a few threats of litigation and career
retaliation along the way for the last three and half a years, I
turned my crazy idea into a reality.”
“But it was only possible,
(Knoepfler) added, with guidance from many patient advocates and
bloggers in other fields who generously helped him learn the ropes of
blogging.
“'I see this award as a validation of
the notion that advocacy by scientists has become a valued part of
the stem cell field,' he said.
“'My hope is to catalyze a continuing
paradigm shift whereby stem cell scientists and biomedical scientists
more generally have a new ethos that not just accepts, but also
deeply values advocacy.'”
Source:Stem Cell Therapy
Comments Off on ‘Paradigm Shift’ — Researchers as Patient Advocates? |
August 18th, 2013
Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India. – Video
By JoanneRUSSELL25
Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India.
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Dee...
By: Neurogen Brain and Spine Institute
See the original post:
Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India. - Video
Uncategorized
Comments Off on Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India. – Video |
August 17th, 2013
Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the Adult Stem Cell Therapy and Regenerative …
By daniellenierenberg
Poway, California (PRWEB) August 15, 2013
Robert J. Harman, DVM, Chief Executive Officer of Vet-Stem, Inc., a leading Regenerative Veterinary MedicineTM company located in San Diego, California, has been invited back to speak at the Adult Stem Cell Therapy and Regenerative Medicine Conference in Cleveland, Ohio August 19-21, 2013. The conference is presented by The National Center for the Regenerative Medicine (NCRM), Case Western Reserve University (CWRU), Cleveland Clinic (CC), and University Hospitals Case Medical Center (UHCMC) to bring together a global perspective on regenerative medicine and adult stem cell therapy.
Dr. Harman is scheduled as the first speaker of Session II titled Disease Models for Adult Stem Cell Therapy, and his presentation is One Medicine Natural Veterinary Disease Models.
He stands alone in his expertise in the field of Regenerative Veterinary Medicine among the 273 attendees from 100 institutions in 17 countries that make up the conference. Dr. Harman draws his knowledge from more than 10,000 horse, dog and cat patients treated over the last 10 years in both the U.S. and Canada using proprietary Vet-Stem technology.
Dr. Harman is sharing the podium with Case Western Reserve Universitys own Dr. Arnold Caplan, and revolutionary regenerative medicine companies such as BioTime, Terumo BCT, STROMALab, and Pfizer. Dr. Caplan, a technology pioneer in cell-based therapies in Regenerative Medicine, is a scientific advisor to Vet-Stem, Inc.
About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.
See the original post here:
Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the Adult Stem Cell Therapy and Regenerative ...
Uncategorized
Comments Off on Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the Adult Stem Cell Therapy and Regenerative … |
August 16th, 2013
NIH joins opposition to charging patients for experimental stem cell therapy
By LizaAVILA
By: Jet Villa, InterAksyon.com August 16, 2013 8:24 AM
InterAksyon.com The online news portal of TV5
MANILA, Philippines -- (UPDATE - 10:12 a.m.) A consultant of Secretary Enrique Ona resigned Friday, calling the Health chiefs position that patients undergoing experimental stem cell therapy should pay unacceptable.
Dr. Anthony Leachon, who is in Davao City, said he emailed his resignation letter to Ona.
It is with deep regret that I'm resigning asDepartment of Health consultant for non-communicable diseases effective today (Friday). I have been privileged and honored to be a part of your administration even as a one peso a year consultant. I value our friendship and camaraderie which started years ago, Leachon, vice president of the Philippine College of Physicians and Onas consultant for non-communicable diseases, wrote.
Because his position is directly opposed to Onas, Leachon told the Health secretary, I believe I have lost your trust and confidence and I might not be effective serving the DOH and fighting the PCP and medical societies ' cause in the service of the Filipino patient.
Leachon was Onas consultant for non-communicable diseases since November 2011.
Ang pinaka-hindi ko nagustuhan ay yung sisingilin ang pasyente kahit clinical trial pa lang. Yon ang unacceptable sa akin (What I disagree with most is charging patients even if what they undergo are just clinical trials. That is unacceptable), Leachon said.
His resignation came as the National Health Institute, the research arm for health sciences of the University of the Philippines-Manila, joined the growing opposition to the Health secretarys stand on experimental stem cell therapy.
Leachon, a cardiologist at the Manila Doctors Hospital, called Onas position a complete violation of the Code of Ethics (for doctors) and being the secretary of health, alam niya dapat yon (he should know that). This is not a sign of ignorance, pero siguro may mga taong iba ang sinasabi sa kaniya (but there may be people telling him otherwise).
Visit link:
NIH joins opposition to charging patients for experimental stem cell therapy
Uncategorized
Comments Off on NIH joins opposition to charging patients for experimental stem cell therapy |
August 16th, 2013
Consultant quits over DOH chief's stand on stem cell therapy
By JoanneRUSSELL25
By: Jet Villa, InterAksyon.com August 16, 2013 8:24 AM
InterAksyon.com The online news portal of TV5
MANILA, Philippines -- (UPDATE - 10:12 a.m.) A consultant of Secretary Enrique Ona resigned Friday, calling the Health chiefs position that patients undergoing experimental stem cell therapy should pay unacceptable.
Dr. Anthony Leachon, who is in Davao City, said he emailed his resignation letter to Ona.
It is with deep regret that I'm resigning asDepartment of Health consultant for non-communicable diseases effective today (Friday). I have been privileged and honored to be a part of your administration even as a one peso a year consultant. I value our friendship and camaraderie which started years ago, Leachon, vice president of the Philippine College of Physicians and Onas consultant for non-communicable diseases, wrote.
Because his position is directly opposed to Onas, Leachon told the Health secretary, I believe I have lost your trust and confidence and I might not be effective serving the DOH and fighting the PCP and medical societies ' cause in the service of the Filipino patient.
Leachon was Onas consultant for non-communicable diseases since November 2011.
Ang pinaka-hindi ko nagustuhan ay yung sisingilin ang pasyente kahit clinical trial pa lang. Yon ang unacceptable sa akin (What I disagree with most is charging patients even if what they undergo are just clinical trials. That is unacceptable), Leachon said.
His resignation came as the National Health Institute, the research arm for health sciences of the University of the Philippines-Manila, joined the growing opposition to the Health secretarys stand on experimental stem cell therapy.
Leachon, a cardiologist at the Manila Doctors Hospital, called Onas position a complete violation of the Code of Ethics (for doctors) and being the secretary of health, alam niya dapat yon (he should know that). This is not a sign of ignorance, pero siguro may mga taong iba ang sinasabi sa kaniya (but there may be people telling him otherwise).
The rest is here:
Consultant quits over DOH chief's stand on stem cell therapy
Uncategorized
Comments Off on Consultant quits over DOH chief's stand on stem cell therapy |
August 16th, 2013
Solon calls for probe into stem cell therapy
By raymumme
by Buena Bernal Posted on 08/15/2013 7:59 PM |Updated 08/16/2013 12:05 AM
PROBE STEM CELL THERAPY. Rep Paulino 'Doy' Leachon files a resolution to probe the conduct of stem cell therapy in the Philippines. Photo grabbed from islandsentinel.com
MANILA, Philippines - Rep Paulino Salvador "Doy" Leachon of Oriental Mindoro's 1st district filed on Thusday, August 15, a house resolution calling for a congressional inquiry in aid of legislation on the conduct of stem cell therapy in the country.
House Resolution 215 was filed a day after Leachon's scheduled privilege speech, calling for the resignation of Health Secretary Enrique Ona over the cabinet official's stand on stem cell therapy.
READ: Leachon asks Ona to resign over stem cell issue
The 40-year-old lawmaker also urged concerned government agencies to step up their regulatory oversight. These agencies include the Department of Health (DOH), the Food and Drug Administration (FDA), and the Professional Regulation Commission (PRC).
First attempt to regulate
Government regulation of stem cell treatment is still in its infancy stage, with the guidelines for accreditation of facilities released only in March.
It is DOH's first attempt at regulating the practice, despite the therapy having been administered by Filipino physicians for years now.
The types of stem cell treatment that are allowed, prohibited, and restricted (i.e. allowed but with limitations) in the facilities to be accredited by August 31 are listed in the released guidelines.
Read the original here:
Solon calls for probe into stem cell therapy
Uncategorized
Comments Off on Solon calls for probe into stem cell therapy |
August 16th, 2013
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talk show on stem cell therapy treatment – Video
By JoanneRUSSELL25
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talk show on stem cell therapy treatment
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Brain Related different types diseases and for them effective Stem Cell Therapy Treatments Stem...
By: Neurogen Brain and Spine Institute
See the original post here:
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talk show on stem cell therapy treatment - Video
Uncategorized
Comments Off on Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talk show on stem cell therapy treatment – Video |
August 15th, 2013
Stem Cell Therapy Treatment for Congenital Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. – Video
By Dr. Matthew Watson
Stem Cell Therapy Treatment for Congenital Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Congenital Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy ...
By: Neurogen Brain and Spine Institute
Uncategorized
Comments Off on Stem Cell Therapy Treatment for Congenital Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. – Video |
August 15th, 2013
My Stem Cell Therapy Fundraiser – Video
By NEVAGiles23
My Stem Cell Therapy Fundraiser
Explain how I was able to raise funds toward my Stem Cell Therapy to treat Multiple Sclerosis...
By: Tiffany Talks Multiple Sclerosis
Read this article:
My Stem Cell Therapy Fundraiser - Video
Uncategorized
Comments Off on My Stem Cell Therapy Fundraiser – Video |
August 15th, 2013
NewsLife: DOH calls for registration of stem cell therapy operators – Video
By daniellenierenberg
NewsLife: DOH calls for registration of stem cell therapy operators
NewsLife - DOH calls for registration of stem cell therapy operators (Reported By: Noel Perfecto) - [August 12, 2013] For more news, visit: #9659;http://www.ptvne...
By: PTV PH
Read more here:
NewsLife: DOH calls for registration of stem cell therapy operators - Video
Uncategorized
Comments Off on NewsLife: DOH calls for registration of stem cell therapy operators – Video |
August 14th, 2013
Bill filed to regulate stem cell therapy in PH
By LizaAVILA
By Christian V. Esguerra Philippine Daily Inquirer
La Union Rep. Eufranio Eriguel. Photo from congress.gov.ph
MANILA, PhilippinesA congressman has joined the call to regulate stem cell therapy administered in the country.
La Union Rep. Eufranio Eriguel has introduced House Bill No. 212, which would put up a bioethics advisory board that would establish ethical standards governing the practice of stem cell research and therapy.
Under the proposed Stem Cell Research and Therapy Act of 2013, the board shall be responsible for addressing contentious ethical, scientific and legal issues in stem cell and cell-based or cellular research and therapies.
There is much to be learned from stem cell therapy, its benefits and application in the cure of some of the most devastating diseases and conditions. As of now, the full promise of stem cell treatment remains unknown, Eriguel said in a statement.
But the cost far outweighs its benefits because it is very expensive and only a few physicians are trained to do stem cell procedures here in the Philippines.
In his proposal, the board will be headed by the health secretary and the National Transplant Ethics Committee, while the Food and Drug Administration director will serve as vice chairman.
A proposed institutional review committee will be tasked to approve stem cell and cell-based or cellular research and therapies based on existing Department of Health guidelines.
Follow Us
Continued here:
Bill filed to regulate stem cell therapy in PH
Uncategorized
Comments Off on Bill filed to regulate stem cell therapy in PH |
August 14th, 2013
DOH gives health facilities engaged in stem cell therapy until Aug. 31 to register
By Sykes24Tracey
By: Jet Villa, InterAksyon.com August 13, 2013 8:42 AM
InterAksyon.com The online news portal of TV5
MANILA, Philippines - The Department of Health (DOH) has given all health facilities practicing stem cell therapy and companies importing and producing stem cell products untilAug. 31to apply for accreditation and product registration, respectively.
Nick Lutero, director of the DOH-Bureau of Health Facilities and Services, said it will be considered illegal for facilities to do stem cell procedures if they fail to comply with the requirement.
Papatigil namin ang pag-conduct ng therapy. For those still continuing to practice, I think we have sufficient laws, particularly on the illegal practice of medicine. They could be criminally liable, he said in a chance interview.
Lutero lamented that only five hospitals have applied for registration although the DOH had issued the guidelines on this since March.
We have done preliminary visits sa mga hospitals na ito at mukang based sa initial inspection, merong sufficient compliance sa mga facilities, he said.
Companies importing and producing stem cell products, on the other hand, should apply for registration with the Food and Drug Administration, an agency attached to the DOH.
Products that will not be applied for registration will also be considered illegal after the deadline.
Experimental treatment not for free
See original here:
DOH gives health facilities engaged in stem cell therapy until Aug. 31 to register
Uncategorized
Comments Off on DOH gives health facilities engaged in stem cell therapy until Aug. 31 to register |
August 13th, 2013
DOH sets deadline for stem cell therapy accreditation
By NEVAGiles23
Manila, Philippines -- Hospitals and health facilities offering stem cell therapy have until August 31 to apply for accreditation from the Department of Health (DoH).
DoH Secretary Enrique T. Ona said a number of hospitals in Metro Manila have already applied for accreditation to perform this "innovative" treatment that has not yet been accepted as standard mode of care in the country since it needs further tests and several more layers of research.
In the first mid-year convention of the Philippine Society for Stem Cell Medicine at the Manila Hotel yesterday, Ona reiterated that stem cell therapy is "the future of medicine."
"Stem cell therapy is not a cure-all medical treatment. Patients have yet to be presented first with standard of treatment, and in many cases, stem cell treatments have to be done in conjunction with other standard modalities of treatment," he said.
The Bureau of Health Facilities and Services (BHFS) of the DoH is accepting the applications for accreditation while a bio-ethics committee and a hospital-based review board will go over the applications and decide on their approval.
Five big hospitals in Metro Manila have already applied for accreditation, said Nick Lutero, chief of the BHFS.
Lutero said initial checks have revealed that these hospitals possess the required equipment needed for the treatment but they would still have to check on requirements set by the Food and Drug Administration (FDA) in relation to the practice.
Lutero said institutions that are offering stem cell treatments can still perform the procedures pending the approval of applications. However, once formal accreditations are already given, unaccredited institutions should cease offering stem cell therapy.
More here:
DOH sets deadline for stem cell therapy accreditation
Uncategorized
Comments Off on DOH sets deadline for stem cell therapy accreditation |
August 12th, 2013
Editorial: Philippine Society for Stem Cell Medicine and Philippine Medical Association 1st Midyear Convention to be …
By raymumme
Two organizations of Filipino medical practitioners - the Philippine Medical Association (PMA) and the Philippine Society for Stem Cell Medicine (PSSCM) - are partnering to come up with ideas to help professionalize and organize the practice of stem cell therapy in the Philippines during their 1st Midyear Convention at the Historic Landmark Manila Hotel on August 12-13, 2013.
With the theme ''Current Status of the Practice of Stem Cell Therapy in the Philippines,'' the convention is expected to take up various issues surrounding stem cell therapy, which, despite the controversies, is increasingly becoming popular for treatment of certain illnesses. Among the scheduled topics for discussion in the convention are Food and Drug Administration Circular on Stem Cell Products, DOH Stem Cell Guidelines, Current Trends on Stem Cell Therapy, Clinical Use of Autologous, Adipose Derived Stem Cells, Photo-Activated Platelet-Rich Plasma for Orthopedic and Rehabilitation Applications, Umbilical Cord Blood and Cord Tissue for Stem Cell Therapy, Stem Cell Therapy in the Philippines other than for Cancer Rejuvenation, and Quality Control in Cell Transplantation.
Administrative Order 2013-0012 issued by the Department of Health (DOH) rules on the practice of stem cell, cell-based therapy, and accreditation of health facilities engaging in the treatment in the Philippines. The Professional Regulation Commission Board of Medicine (PRCBOM) requires foreign doctors wishing to practice stem cell therapy in the country to get a special temporary permit, citing their education, training, and clinical experience.
The PMA, the country's premier medical organization, has 70,000 members in 118 component medical societies, eight specialty divisions, 73 specialty and subspecialty societies, and 39 affiliate societies all over the archipelago, who advocate professional advancement and promote public health. The newly founded PSSCM is composed of physicians doing stem cell therapy and transplant. It is working closely with DOH, PRCBOM, and PMA to regulate the practice of Stem Cell therapy and protect patients.
We congratulate the Philippine Medical Association, headed by its President Dr. Leo O. Olarte, and the Philippine Society for Stem Cell Medicine, led by Dr. Rey Melchor F. Santos, in their coordinative efforts to educate and inform the public on the status of stem cell treatment as a novel medical approach in the Republic of the Philippines. CONGRATULATIONS AND MABUHAY!
Read this article:
Editorial: Philippine Society for Stem Cell Medicine and Philippine Medical Association 1st Midyear Convention to be ...
Uncategorized
Comments Off on Editorial: Philippine Society for Stem Cell Medicine and Philippine Medical Association 1st Midyear Convention to be … |
August 11th, 2013
Laser And Optical Tweezers Insert DNA Into Cell ‘Like A Golfer Sinking An Easy … – Headlines & Global News
By Dr. Matthew Watson
 Headlines & Global News | Laser And Optical Tweezers Insert DNA Into Cell 'Like A Golfer Sinking An Easy ... Headlines & Global News (Photo : Optical Society). Scientists have created an ultra-precise way to inject DNA into a cell. Genetic engineering is used for a large number of applications, but the methods are extremely shaky, an Optical Society press release reported. Share ... New high-tech laser method allows DNA to be inserted 'gently' into living cellsNanowerk New high-tech laser technique allows DNA to be inserted 'gently' into cellsScience Recorder |
Uncategorized
Comments Off on Laser And Optical Tweezers Insert DNA Into Cell ‘Like A Golfer Sinking An Easy … – Headlines & Global News |
August 11th, 2013
Time to reap the biotechnology harvest – Hindustan Times
By Dr. Matthew Watson
Time to reap the biotechnology harvest Hindustan Times Biotechnology is one such area. The past decades have seen ground-breaking research in this field that has transformed agriculture in much of the world. India has had to play catch up, and despite having one of the most robust regulatory frameworks ... Biotechnology: A key platform for sustainable economic growth (2)The Guardian Nigeria |
Uncategorized
Comments Off on Time to reap the biotechnology harvest – Hindustan Times |
August 11th, 2013
Manufacturers urged to ’embrace’ biotechnology – E&T magazine
By Dr. Matthew Watson
 E&T magazine | Manufacturers urged to 'embrace' biotechnology E&T magazine Leading manufacturers and the Industrial Biotechnology Leadership Forum are promoting the varied applications of biotechnology at an exhibition in the Department for Business, Innovation and Skills, which Business and Energy Minister Michael Fallon ... |
Uncategorized
Comments Off on Manufacturers urged to ’embrace’ biotechnology – E&T magazine |
August 11th, 2013